Google Alert - pharmaceutical news

News 10 new results for pharmaceutical news

Department of Pharmaceuticals examining mechanism for pricing patented ... Economic Times In case, a company increases the prices beyond 10 per cent, the specific cases are taken up by National Pharmaceutical Pricing Authority (NPPA) with the respective companies for rolling back the increase with in the limit of 10 per cent, he added. See all stories on this topic »

DIPP to take call on allowing 49 per cent FDI in pharmaceutical firms Economic Times NEW DELHI: An inter-ministerial group has asked the Department of Industrial Policy and Promotion (DIPP) to consider allowing foreign direct investment of up to 49 per cent through automatic route in existing Indian pharmaceutical firms. A special ... See all stories on this topic »

Govt plans to introduce 'Uniform Code of Pharmaceutical Marketing Practices' Hindu Business Line The government is planning to introduce 'Uniform Code of Pharmaceutical Marketing Practices' to deal with the alleged nexus between doctors and drug companies, the Lok Sabha was informed on Friday. Health Minister, Ghulam Nabi Azad, in his written ... See all stories on this topic »

Ranbaxy launches generic diabetes treatment tablets in US IBNLive.com The company's wholly-owned subsidiary Ranbaxy Pharmaceuticals Inc has launched the drug following the expiry of patent held by Takeda Pharmaceutical. Ranbaxy is among the three companies, including Teva and Mylan, to have 180-days of marketing ... See all stories on this topic » IBNLive.com

6 Pharmaceutical Stocks to Buy Now Investorplace.com Six Pharmaceutical stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy"). Allergan (NYSE:AGN) ups its rating to a B ("buy") this ... See all stories on this topic »

BioSante Pharmaceuticals to Raise $3475000 in Registered Direct Offering 4-traders BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced that it has received a commitment from an institutional investor to purchase $3475000 of securities in a registered direct offering. BioSante expects to receive net proceeds of approximately ... See all stories on this topic »

Cipla hopeful of achieving 12-15 per cent revenue growth in FY13 Economic Times Commenting on future plans, Hamied said the company has over 100 granted patents on APIs (active pharmaceutical ingredients), formulations and medical devices. In USA, Cipla has over 130 Drug Master Files (DMFs) for active ingredients, 105 registered ... See all stories on this topic »

Cinven buys Mercury Pharma for £465m New Statesman The European private equity firm Cinven has acquired the UK-based Mercury Pharma Group from HgCapital, for an enterprise value of £465m. The deal is expected to close by the end of August. Headquartered in Surrey, Mercury has operational bases in the ... See all stories on this topic »

Rhizen Pharmaceuticals, TG Therapeutics collaborate on PI3K delta inhibitor Pharmaceutical Business Review TG Therapeutics and Rhizen Pharmaceuticals have collaborated to develop and commercialise Rhizen PI3K delta inhibitor, TGR-1202 previously referred as RP5264. As part of the collaboration, the companies will develop TGR-1202 on a worldwide basis, ... See all stories on this topic »

Pharma Professionals of The Decade at 5th Annual Pharmaceutical Leadership ... Orissadiary.com Report by OD bureau; Mumbai: Indian Pharmaceutical & Biotech Industry over the years has evolved out in the global map as the leading destination & manufacturing hub for sourcing pharmaceutical API's & Formulations. Indian Pharmaceutical Sector has ... See all stories on this topic » Orissadiary.com

---

Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.

Delete this alert.
Create another alert.
Manage your alerts.